Marek Szwiec
Szwiec, Marek.
VIAF ID: 1319148997629359870006 (Personal)
Permalink: http://viaf.org/viaf/1319148997629359870006
Preferred Forms
- 100 0 _ ‡a Marek Szwiec
-
-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population | |
BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation | |
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer | |
Breast cancer (BC) phenotypes in small invasive tumors (pT1a/b pN0). | |
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband | |
Charakterystyka molekularna i rodowodowo - kliniczna dziedzicznego raka piersi w województwie opolskim : rozprawa doktorska | |
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis | |
Germline RECQL mutations are associated with breast cancer susceptibility | |
A high proportion of founder BRCA1 mutations in Polish breast cancer families | |
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations | |
Inherited variants in XRCC2 and the risk of breast cancer | |
Lynch syndrome mutations shared by the Baltic States and Poland. | |
Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016. | |
New EPCAM founder deletion in Polish population | |
PALB2 mutations and prostate cancer risk and survival | |
Patients' Non-Medical and Organizational Needs during Cancer Diagnosis and Treatment | |
A practical approach to the 2022 ESC cardio-oncology guidelines : comments by a team of experts cardiologists and oncologists | |
Recurrent mutations of BRCA1 and BRCA2 in Poland: an update | |
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers | |
Selenium and the risk of cancer in BRCA1 carriers. | |
The spectrum of mutations predisposing to familial breast cancer in Poland | |
A survey of preventive measures among BRCA1 mutation carriers from Poland | |
Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer |